Gynecologic Oncology Center

Free consultation

A gynecologic oncologist can read your file before you consider a flight

Reading your file is free and commits you to nothing. Send your pathology report, your MRI, CT or PET reports, your CA-125 or other tumor marker results, and, if you have not yet reached menopause, a line about whether future pregnancy matters to you. You receive a written opinion on the diagnosis, on whether surgery now or chemotherapy first is the sounder sequence, and on how many days in Istanbul a realistic plan would need.

Which cancers the Gynecologic Oncology Center treats

The Gynecologic Oncology Center treats cervical cancer, endometrial cancer (cancer of the lining of the uterus), ovarian cancer together with fallopian tube and primary peritoneal cancer, and the rarer cancers of the vulva and vagina. Its work also covers borderline ovarian tumors, complex pelvic masses where cancer has to be ruled out before anyone decides on an operation, and high-grade precancerous disease of the cervix, which is removed with a small excisional procedure rather than cancer surgery. Cervical cancer has one unusual property worth naming early: a landmark pathology study found human papillomavirus in virtually all invasive cervical cancers worldwide (Walboomers and colleagues, Journal of Pathology, 1999), which is why HPV testing and vaccination sit behind so much of modern prevention.

The center is built around the Gynecological Oncology department of a university hospital with more than 600 beds. That setting is the point, not a boast. A woman with ovarian cancer may need a long operation, intensive care afterward, chemotherapy in the weeks that follow and genetic testing that changes her family's screening; a woman with locally advanced cervical cancer may need radiotherapy with weekly chemotherapy and no operation at all. So the surgical team plans each case together with medical oncology, radiation oncology, pathology, radiology and interventional radiology, genetics, and gynecology and obstetrics, with intensive care in the same building. Before a treatment date is fixed, the specialties concerned look at the same pathology and the same images and agree on the sequence, which is the accepted standard for gynecologic cancer and the reason a plan here is a joint judgment rather than one surgeon's preference.

One warning sign belongs on this page in plain words. Vaginal bleeding after menopause is not normal, whatever its amount, and it deserves a gynecologic evaluation promptly, wherever you live. Most causes turn out to be benign, but endometrial cancer has to be excluded, and excluding it early is exactly what makes it one of the more curable cancers. Do not park that symptom while you compare hospitals abroad; see a doctor near home first, then decide about travel with a diagnosis in hand.

What the surgical evidence shows, cancer by cancer

Keyhole surgery is marketed everywhere as the modern choice, and for many operations it is. Gynecologic oncology is the specialty where that assumption has been tested hardest, and the results are worth reading before you compare any two hospitals, because they separate centers that follow evidence from centers that follow brochures.

Cervical cancer: why the open operation is the standard

The LACC trial, published in the New England Journal of Medicine in 2018, randomized women with early cervical cancer between minimally invasive and open radical hysterectomy. Minimally invasive surgery was associated with lower disease-free survival and lower overall survival than the open operation (Ramirez and colleagues). That finding reshaped international practice: for early cervical cancer, open radical hysterectomy is the evidence-backed route, and smaller incisions are not worth a worse cancer outcome. This center chooses the surgical route on that evidence. If a hospital you are comparing proposes laparoscopic or robotic radical hysterectomy for cervical cancer, ask it to explain its reasoning against LACC; the answer will tell you a great deal.

Not every cervical cancer is treated with surgery. Once the disease is locally advanced, the definitive treatment is usually chemoradiation, meaning daily radiotherapy over several weeks with chemotherapy given alongside to sharpen its effect. Radiation Oncology operates within the same hospital, so staging and that treatment decision happen in one place.

Ovarian cancer: the operation is judged by what is left behind

Few numbers in oncology are as blunt as this one. A combined analysis of three prospectively randomized phase 3 trials in advanced epithelial ovarian cancer showed that survival was longest in women whose surgery left no visible tumor behind, and that this completeness of resection was the strongest prognostic factor a treatment team can actually influence (du Bois and colleagues, Cancer, 2009). Stage cannot be changed and biology cannot be chosen. How radical and how complete the operation is can be.

That gives you the two questions to put to any center you are considering, this one included. Will my surgery aim for no visible residual disease, and who exactly will be in the operating room if the disease involves the bowel, the diaphragm or the upper abdomen. Debulking of that kind is long, demanding surgery, and it is the reason ovarian cancer belongs in a hospital where intensive care and additional surgical teams are on site rather than on call elsewhere. When imaging shows disease that cannot be removed completely, the honest plan is chemotherapy first to shrink it, then interval surgery; more on that decision in the travel section, because for a woman abroad it decides the whole shape of the trip.

Endometrial cancer: sentinel nodes instead of removing them all

Surgeons once removed the pelvic lymph nodes wholesale to find out whether an endometrial cancer had spread, and many women paid for that information with lifelong leg swelling. The FIRES trial changed the calculation: sentinel lymph node biopsy, in which a dye identifies the first node draining the tumor so only that node is removed and examined, reliably detected nodal spread in endometrial cancer (Rossi and colleagues, Lancet Oncology, 2017). A negative sentinel node spares the rest, and with them much of the lymphedema risk. Endometrial cancer is also the setting where a minimally invasive operation remains a reasonable choice for many women, which is exactly the point about evidence: the route is picked per cancer, not per fashion.

Chemotherapy, radiotherapy and surgery are not rivals; many plans combine all three in a set order. The hospital's Nuclear Medicine department, including newer radionuclide treatments, and its interventional radiology unit extend what can be offered when a case sits outside the usual patterns.

Fertility, menopause and what must be decided before surgery

Surgery that removes both ovaries ends fertility and, in a woman who has not yet reached menopause, starts menopause the same day, without the years of gradual transition. Hot flashes, sleep disruption and bone and heart effects arrive on a surgical timetable. None of this is a reason to refuse a necessary operation. It is a reason to have the conversation before the operation, because afterward the choices are gone.

Fertility-sparing treatment exists, and honesty about it means saying that the door is narrow. Trachelectomy removes the cervix but keeps the uterus for certain small cervical tumors. A carefully selected group of very early, low-grade endometrial cancers can be managed hormonally for a period in women who want to carry a pregnancy first. Borderline ovarian tumors often allow the uterus and an ovary to stay. Eligibility for each of these is decided on pathology and imaging, not on hope, and part of the value of a remote file review is finding out which side of that line you are on before travel, tickets or grief over options you never actually had. Where freezing eggs or embryos before treatment is worth exploring, the hospital's IVF Center is in the same building and that discussion is arranged before the first dose or incision, not after.

Genetics belongs in the same conversation. A meaningful share of ovarian cancers arise on inherited BRCA gene changes, and some endometrial and ovarian cancers point to Lynch syndrome; testing where indicated can alter drug choices, follow-up and what relatives should be screened for. Asking about it costs one sentence in your first message.

How gynecologic cancer treatment fits into a trip abroad

Start from an uncomfortable truth that package pages skip: gynecologic cancer treatment is rarely one event. Surgery alone can fit inside a trip of roughly 10 to 14 days, covering consultations, the operation, several nights in hospital and a wound check before flying. Ovarian cancer, though, usually needs around six chemotherapy cycles spread over months. Chemoradiation for locally advanced cervical cancer runs about five to six weeks of radiotherapy on weekdays, every weekday. These are typical treatment structures, not promises about your case, and they mean a visitor is really choosing between three shapes of trip.

The first shape is the surgical trip: operation in Istanbul, then chemotherapy at home under a local oncologist, working from a written handover that records the surgical findings, the final pathology and the proposed protocol. Chemotherapy regimens for these cancers are internationally standardized, which is what makes the split workable. The second is staying for the whole course, weeks for chemoradiation or an extended period for surgery plus chemotherapy, which some women prefer so that one team sees everything through. The third is the reverse order used in ovarian cancer when complete resection does not look achievable up front: chemotherapy, at home or here, then interval debulking surgery at the planned midpoint. Which shape is realistic for you is exactly what the free file review settles, and it should be settled before anyone buys a ticket.

Pathology can travel ahead of you. Your existing biopsy report and, where your laboratory releases them, the slides or tissue blocks can be re-reviewed here, alongside your images. In ovarian cancer that remote review often is the decision, because "operable now" versus "chemotherapy first" turns on what the CT and the pathology show, and a second written opinion on those two things has value whether or not you ever board a plane. Send the following with your first message:

• the pathology report, with a note on whether your laboratory will release slides or blocks
• MRI, CT or PET reports, with the images themselves if you can obtain them
• CA-125 and other recent laboratory results
• operation notes from any previous surgery, and a summary of any chemotherapy already given
• your medication list
• for premenopausal women, your menstrual status and your wishes about future pregnancy

Practicalities are handled so they do not compete with treatment for your attention: the international office provides interpreter support in your own language and helps with airport transfer and accommodation for you and a companion. Requests that matter to you personally, such as being seen by a female physician, should be raised with the international office at the outset so you have a plain answer before travel.

Follow-up after you return home is planned before discharge, not improvised afterward. You leave with your operative notes, the final pathology and a written surveillance schedule, since gynecologic cancers are watched with examinations, tumor markers and imaging at set intervals for years; a gynecologist or oncologist near home runs that schedule, and questions that come up later travel back over the same WhatsApp channel the whole process started on.

What gynecologic cancer treatment costs in Turkey

Published marketplace figures give a usable frame, provided you read what sits inside each number. Bookimed, a medical tourism platform, lists ovarian cancer surgery packages in Turkey at around $16,500 for hysterectomy with removal of both tubes and ovaries plus lymph node dissection, eight hospital nights with intensive care and transfers included; robotic versions at around $20,000 with three nights; and cytoreductive surgery with heated intraperitoneal chemotherapy, HIPEC, from $23,380 to $49,900 covering seven to twenty nights. Across its listed clinics, total ovarian cancer spending spans $800 to $45,000. For cervical cancer, the aggregator amedical.az places treatment in Turkey between $4,000 and $20,000 depending on stage and protocol. All of these are third-party figures, quoted here so you can compare like with like rather than as an offer.

The spread is that wide because five things move the price: the stage and therefore the extent of surgery, whether HIPEC is part of the plan, how many hospital nights and intensive care days are involved, whether chemotherapy or radiotherapy is delivered during the stay or handed over to your home team, and what pathology and genetic testing the case requires. Two women with "ovarian cancer" on paper can need operations that differ by hours and hospital stays that differ by weeks. For that reason the center does not quote from a price list; after the file review you receive a written individual quotation stating what it covers, so the figure you compare is the figure you would pay.

Questions women and families ask

References

1. Ramirez PT, Frumovitz M, et al. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. New England Journal of Medicine. 2018;379(20):1895-1904.
2. du Bois A, Reuss A, et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials. Cancer. 2009;115(6):1234-1244.
3. Rossi EC, Kowalski LD, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncology. 2017;18(3):384-392.
4. Walboomers JM, Jacobs MV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology. 1999;189(1):12-19.